Pneumococcal Vaccine Market Expanding with Inclusion in Publicly-Funded Vaccination Programs

January 16, 2015
A pneumococcal vaccine for elderly persons aged 65 and over was added to publicly-funded vaccination programs in October, when the likelihood of an influenza outbreak was increasingly raising concerns about complications in the elderly. This situation has stimulated the pneumococcal...read more